Argenx to report third quarter 2024 financial results and business update on october 31, 2024

October 24, 2024 amsterdam, the netherlands – argenx (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on thursday, october 31, 2024 at 1:30 pm cet (8:30 am et) to discuss its third quarter 2024 financial results and provide a business update.
ARGX Ratings Summary
ARGX Quant Ranking